Effects of medication intake on the risk of hemorrhage in patients with sporadic cerebral cavernous malformations

Rabbit Elastase Aneurysm: Imaging and Histology Correlates for Inflammation and Healing

(2021) James P. Ho et al.   World Neurosurgery

Effect of combined acetylsalicylic acid and statins treatment on intracranial aneurysm rupture

(2021) Mikel Terceño et al.   PLoS One

Modifiable Cardiovascular Risk Factors in Patients With Sporadic Cerebral Cavernous Malformations

(2021) Bixia Chen et al.   STROKE

Aspirin treatment prevents inflammation in experimental bifurcation aneurysms in New Zealand White rabbits

(2021) Stefan Wanderer et al.   Journal of NeuroInterventional Surgery

The Role of Aspirin in the Management of Intracranial Aneurysms: A Systematic Review and Meta-Analyses

(2021) Shuwen Yang et al.   Frontiers in Neurology

Role of aspirin and statin therapy in patients with cerebral cavernous malformations

(2020) Santiago Gomez-Paz et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Propranolol for familial cerebral cavernous malformation (Treat_CCM): study protocol for a randomized controlled pilot trial

(2020) Silvia Lanfranconi et al.   Trials

Hemorrhage from cerebral cavernous malformations

(2020) Bixia Chen et al.   NEUROLOGY

Symptomatic cavernous malformation presenting with seizure without hemorrhage: Analysis of factors influencing clinical presentation

(2019) Edoardo Agosti et al.   World Neurosurgery

Aspirin and Intracranial Aneurysms

(2019) Joseph S. Hudson et al.   STROKE

Long-term antithrombotic therapy and risk of intracranial haemorrhage from cerebral cavernous malformations: a population-based cohort study, systematic review, and meta-analysis

(2019) Susanna M Zuurbier et al.   LANCET NEUROLOGY

Predictors of Initial Presentation with Hemorrhage in Patients with Cavernous Malformations

(2019) Kelly D. Flemming et al.   World Neurosurgery

The influence of thyroid function on the coagulation system and its clinical consequences

(2018) L. P. B. Elbers et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

A benchmark approach to hemorrhage risk management of cavernous malformations

(2018) Sepide Kashefiolasl et al.   NEUROLOGY

Cranial Cavernous Malformations

(2018) Christopher J. Stapleton et al.   STROKE

Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice

(2018) Miguel Alejandro Lopez-Ramirez et al.   BLOOD

Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial

(2018) Sean P Polster et al.   NEUROSURGERY

Hemorrhage from cerebral cavernous malformations: a systematic pooled analysis

(2017) Bradley A. Gross et al.   JOURNAL OF NEUROSURGERY

Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations: Consensus Recommendations Based on Systematic Literature Review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel

(2017) Amy Akers et al.   NEUROSURGERY

Combined HMG-COA reductase and prenylation inhibition in treatment of CCM

(2017) Sayoko Nishimura et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Propranolol stops progressive multiple cerebral cavernoma in an adult patient

(2016) Matthias Reinhard et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Top ten research priorities for brain and spine cavernous malformations

(2016) Rustam Al-Shahi Salman et al.   LANCET NEUROLOGY

Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data

(2016) Margaret A Horne et al.   LANCET NEUROLOGY

Natural history of cavernous malformation

(2016) Shervin Taslimi et al.   NEUROLOGY

Solitary Sporadic Cerebral Cavernous Malformations: Risk Factors of First or Recurrent Symptomatic Hemorrhage and Associated Functional Impairment

(2016) Philipp Dammann et al.   World Neurosurgery

Propranolol Treatment of Cavernous Malformations with Symptomatic Hemorrhage

(2016) Joseph M. Zabramski et al.   World Neurosurgery

Association of Cardiovascular Risk Factors with Disease Severity in Cerebral Cavernous Malformation Type 1 Subjects with the Common Hispanic Mutation

(2014) Hélène Choquet et al.   CEREBROVASCULAR DISEASES

Treatment of cerebral cavernous malformations: a systematic review and meta-regression analysis

(2014) Michiel H F Poorthuis et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

A risk factor analysis of prospective symptomatic haemorrhage in adult patients with cerebral cavernous malformation

(2014) Jin Sue Jeon et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Clinical course of untreated pediatric brainstem cavernous malformations: hemorrhage risk and functional recovery

(2014) Da Li et al.   Journal of Neurosurgery-Pediatrics

Evidence That Acetylsalicylic Acid Attenuates Inflammation in the Walls of Human Cerebral Aneurysms: Preliminary Results

(2013) David M. Hasan et al.   Journal of the American Heart Association

The 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) pathway regulates developmental cerebral-vascular stability via prenylation-dependent signalling pathway

(2012) Shahram Eisa-Beygi et al.   DEVELOPMENTAL BIOLOGY

Untreated clinical course of cerebral cavernous malformations: a prospective, population-based cohort study

(2012) Rustam Al-Shahi Salman et al.   LANCET NEUROLOGY

Prospective hemorrhage risk of intracerebral cavernous malformations

(2012) K. D. Flemming et al.   NEUROLOGY

Propranolol Treatment for a Giant Infantile Brain Cavernoma

(2010) Maria Moschovi et al.   JOURNAL OF CHILD NEUROLOGY

Hemorrhage From Cavernous Malformations of the Brain

(2008) Rustam Al-Shahi Salman et al.   STROKE